Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: Acohort study
(2020)
Journal Article
Fenton, A., Chinnadurai, R., Gullapudi, L., Kampanis, P., Dasgupta, I., Ritchie, J., …Cockwell, P. (2020). Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: Acohort study. PLoS Medicine, 17(2), Article e1003050. https://doi.org/10.1371/journal.pmed.1003050
BACKGROUND: In studies including the general population, the presence of non-malignant monoclonal gammopathy (MG) can be causally associated with kidney damage and shorter survival. We assessed whether the presence of an MG is associated with a highe... Read More about Association between non-malignant monoclonal gammopathy and adverse outcomes in chronic kidney disease: Acohort study.